BioAtla, Inc. — Investor Relations & Filings
Filings indexed
474
across all filing types
Latest filing
2026-05-15
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
BCAB
BioAtla, Inc. is a clinical-stage biopharmaceutical company that develops novel antibody-based therapeutics for the treatment of solid tumor cancers. The company's core focus is its proprietary Conditionally Active Biologics™ (CAB) platform. This technology is engineered to create protein therapeutics, including monoclonal antibodies, that are activated specifically within the physiological conditions of the tumor microenvironment. The primary goal of this approach is to enhance the therapeutic index of its drugs, making them safer and more effective by concentrating their activity on cancerous cells while minimizing damage to healthy tissue.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q | 2026-05-15 | English | |
| 8-K - BioAtla, Inc. (0001826892) (Filer) | 2026-03-23 | English | |
| 4 - BIOATLA, INC. (0001826892) (Filer) | 2026-03-03 | English | |
| 4 - BIOATLA, INC. (0001826892) (Filer) | 2026-03-03 | English | |
| 4 - BIOATLA, INC. (0001826892) (Filer) | 2026-03-03 | English | |
| 4 - BIOATLA, INC. (0001826892) (Filer) | 2026-03-03 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
14 filings
| |||||
| 46361745 | 10-Q | 2026-05-15 | English | ||
| 33016202 | 8-K - BioAtla, Inc. (0001826892) (Filer) | 2026-03-23 | English | ||
| 32899213 | 4 - BIOATLA, INC. (0001826892) (Filer) | 2026-03-03 | English | ||
| 32899214 | 4 - BIOATLA, INC. (0001826892) (Filer) | 2026-03-03 | English | ||
| 32899215 | 4 - BIOATLA, INC. (0001826892) (Filer) | 2026-03-03 | English | ||
| 32899216 | 4 - BIOATLA, INC. (0001826892) (Filer) | 2026-03-03 | English | ||
| 32899217 | 8-K - BIOATLA, INC. (0001826892) (Filer) | 2026-03-02 | English | ||
| 31934908 | DEFM14A Filing | 2026-02-11 | English | ||
| 32899218 | 8-K - BIOATLA, INC. (0001826892) (Filer) | 2026-02-09 | English | ||
| 31934881 | 8-K Filing | 2026-02-06 | English | ||
| 31934888 | 8-K Filing | 2026-01-30 | English | ||
| 13314198 | S-3 | 2026-01-16 | English | ||
| 13314199 | DEFA14A | 2026-01-15 | English | ||
| 13314200 | 8-K | 2026-01-12 | English | ||
|
2025
1 filing
| |||||
| 13314201 | DEFA14A | 2025-12-31 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Adlai Nortye Ltd.
A clinical-stage biopharma firm developing cancer immunothe…
|
ANL | KY | Manufacturing |
|
ADLINE CHEM LAB LIMITED
Produces APIs, chemical intermediates, and specialty chemic…
|
524604 | IN | Manufacturing |
|
ADMA BIOLOGICS, INC.
Biopharmaceutical company that develops and manufactures pl…
|
ADMA | US | Manufacturing |
|
Advectus Life Sciences Inc.
Advances drug delivery systems using proprietary nanopartic…
|
AVXSF | CA | Manufacturing |
|
Adverum Biotechnologies, Inc.
A clinical-stage company developing gene therapies for ocul…
|
ADVM | US | Manufacturing |
|
Advicenne
A specialty pharmaceutical company developing treatments fo…
|
ALDVI | FR | Manufacturing |
|
AegirBio AB
A diagnostics company specializing in therapeutic drug moni…
|
AEGIR | SE | Manufacturing |
|
Aelis Farma
Biopharmaceutical company developing CB1 receptor inhibitor…
|
AELIS | FR | Manufacturing |
|
AEON Biopharma, Inc.
Clinical-stage company developing therapeutic applications …
|
AEON | US | Manufacturing |
|
Aequus Pharmaceuticals Inc.
Developing and commercializing specialty pharmaceutical pro…
|
AQS | CA | Manufacturing |
BioAtla, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34681/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34681 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34681 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34681 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34681}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BioAtla, Inc. (id: 34681)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.